Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics
出版年份 2018 全文链接
标题
Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 12, Pages 4111
出版商
MDPI AG
发表日期
2018-12-19
DOI
10.3390/ijms19124111
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transforming Growth Factor-β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma
- (2018) Christine Haider et al. HEPATOLOGY
- Co-expression of PDGF-B and VEGFR-3 strongly correlates with poor prognosis in hepatocellular carcinoma patients after hepatectomy
- (2018) Bin Chen et al. Clinics and Research in Hepatology and Gastroenterology
- The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
- (2018) Marie-Anne Goyette et al. Cell Reports
- Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
- (2018) Javier A García-Vilas et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Expression and prognostic value of HER-2/neu, STAT3 and SOCS3 in hepatocellular carcinoma
- (2018) Li-Hua Jiang et al. Clinics and Research in Hepatology and Gastroenterology
- Inflammation and cancer
- (2018) Mariko Murata Environmental Health and Preventive Medicine
- Regorafenib for the treatment of unresectable hepatocellular carcinoma
- (2017) Lorenza Rimassa et al. Expert Review of Anticancer Therapy
- Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells
- (2017) Yinzhong Lu et al. FASEB JOURNAL
- Genome-wide screen of gamma-secretase–mediated intramembrane cleavage of receptor tyrosine kinases
- (2017) Johannes A. M. Merilahti et al. MOLECULAR BIOLOGY OF THE CELL
- Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts
- (2017) Kristine Yttersian Sletta et al. PLoS One
- Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis
- (2017) Jung-Hwan Yu et al. Oncotarget
- Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis
- (2017) Mirko Dengler et al. Oncotarget
- Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
- (2017) Xiao-Xiao Ding et al. Oncotarget
- Axl acts as a tumor suppressor by regulating LIGHT expression in T lymphoma
- (2017) Eun-Hee Lee et al. Oncotarget
- RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma
- (2017) Wei Wang et al. Oncotarget
- Apoptotic Cells Induced Signaling for Immune Homeostasis in Macrophages and Dendritic Cells
- (2017) Uriel Trahtemberg et al. Frontiers in Immunology
- YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC
- (2017) Elena Ghiso et al. NEOPLASIA
- HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance
- (2017) et al. Cancers
- TAM receptor tyrosine kinase function and the immunopathology of liver disease
- (2016) S. K. Mukherjee et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Gas6 as a putative noninvasive biomarker of hepatic fibrosis
- (2016) Mattia Bellan et al. Biomarkers in Medicine
- Molecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer
- (2016) Miles A. Miller et al. CLINICAL CANCER RESEARCH
- Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE
- (2016) Jacob J. Orme et al. CLINICAL IMMUNOLOGY
- Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
- (2016) Shao-Lai Zhou et al. GASTROENTEROLOGY
- Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies
- (2016) Mihalis S. Kariolis et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of epithelial to mesenchymal transition in hepatocellular carcinoma
- (2016) Gianluigi Giannelli et al. JOURNAL OF HEPATOLOGY
- MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease
- (2016) Salvatore Petta et al. JOURNAL OF HEPATOLOGY
- Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
- (2016) Alexandra L. Matthews et al. PLATELETS
- Genetic alterations in hepatocellular carcinoma: An update
- (2016) Zhao-Shan Niu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance
- (2016) M. A. Miller et al. Cancer Discovery
- TERT promoter mutations in primary liver tumors
- (2016) Jean-Charles Nault et al. Clinics and Research in Hepatology and Gastroenterology
- Axl-EGFR receptor tyrosine kinase hetero-interaction provides EGFR with access to pro-invasive signalling in cancer cells
- (2016) M Vouri et al. Oncogenesis
- The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy
- (2016) Magdalena Paolino et al. Cancers
- The Receptor Tyrosine Kinase AXL in Cancer Progression
- (2016) Erinn Rankin et al. Cancers
- Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis
- (2015) Amanda Kirane et al. CANCER RESEARCH
- VEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinoma
- (2015) Tao Li et al. Future Oncology
- Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma
- (2015) Patrick Reichl et al. HEPATOLOGY
- Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma
- (2015) Patrick Reichl et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpression of Tyro3 and its implications on hepatocellular carcinoma progression
- (2015) YAN DUAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation
- (2015) Cristina Bárcena et al. JOURNAL OF HEPATOLOGY
- Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia
- (2015) I-K Park et al. LEUKEMIA
- MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells
- (2015) XIAO-YUN LI et al. Oncology Letters
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Axl as a mediator of cellular growth and survival
- (2015) Haley Axelrod et al. Oncotarget
- Transforming Growth Factor- as a Therapeutic Target in Hepatocellular Carcinoma
- (2014) G. Giannelli et al. CANCER RESEARCH
- AXL receptor tyrosine kinase is increased in patients with heart failure
- (2014) M. Batlle et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Receptor Tyrosine Kinases, TYRO3, AXL, and MER, Demonstrate Distinct Patterns and Complex Regulation of Ligand-induced Activation
- (2014) Wen-I Tsou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression
- (2014) Wei Zhang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
- (2014) Magdalena Paolino et al. NATURE
- EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation
- (2014) Hanane Lanaya et al. NATURE CELL BIOLOGY
- An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis
- (2014) Mihalis S Kariolis et al. Nature Chemical Biology
- Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET
- (2014) Erinn B. Rankin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Axl as a downstream effector of TGF-β1 via PI3K/Akt-PAK1 signaling pathway promotes tumor invasion and chemoresistance in breast carcinoma
- (2014) Yanyan Li et al. TUMOR BIOLOGY
- Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma
- (2013) I. Ben-Batalla et al. BLOOD
- Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma
- (2013) Hsin-Jung Lee et al. CARCINOGENESIS
- Identification of driver genes in hepatocellular carcinoma by exome sequencing
- (2013) Sean P. Cleary et al. HEPATOLOGY
- Platelets in Tumor Progression: A Host Factor That Offers Multiple Potential Targets in the Treatment of Cancer
- (2013) Deva Sharma et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Development of a Spontaneous Liver Disease Resembling Autoimmune Hepatitis in Mice Lacking Tyro3, Axl and Mer Receptor Tyrosine Kinases
- (2013) Nan Qi et al. PLoS One
- Axl gene knockdown inhibits the metastasis properties of hepatocellular carcinoma via PI3K/Akt-PAK1 signal pathway
- (2013) Jingchao Xu et al. TUMOR BIOLOGY
- Biology of the TAM Receptors
- (2013) G. Lemke Cold Spring Harbor Perspectives in Biology
- Bringing cancer serological diagnosis to a new level: focusing on HER2, protein ectodomain shedding and neoepitope technology
- (2012) Jianxia Wang et al. Future Oncology
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators
- (2012) Akihiro Fujimoto et al. NATURE GENETICS
- Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice
- (2011) Agnès Fourcot et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Macrophage–tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands
- (2011) Thomas Schmidt et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Galectin-3 is a new MerTK-specific eat-me signal
- (2011) Nora B. Caberoy et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
- (2011) Meng Li et al. NATURE GENETICS
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease
- (2010) L. Burnier et al. BLOOD
- Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma
- (2010) Xianzhou Song et al. CANCER
- R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
- (2010) S. J. Holland et al. CANCER RESEARCH
- Tubby and tubby-like protein 1 are new MerTK ligands for phagocytosis
- (2010) Nora B Caberoy et al. EMBO JOURNAL
- Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury
- (2010) Laura Llacuna et al. HEPATOLOGY
- Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis
- (2010) Christine Gauglhofer et al. HEPATOLOGY
- Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood
- (2010) C. EKMAN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
- (2010) M Z Xu et al. ONCOGENE
- An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies
- (2010) X Ye et al. ONCOGENE
- Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6
- (2009) S. Loges et al. BLOOD
- Anticancer Chemotherapy Inhibits MHC Class I-Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma
- (2009) K. Kohga et al. CANCER RESEARCH
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
- (2009) Sean F. Altekruse et al. JOURNAL OF CLINICAL ONCOLOGY
- Growth arrest-specific protein 6 deficiency impairs liver tissue repair after acute toxic hepatitis in mice
- (2009) Fouad Lafdil et al. JOURNAL OF HEPATOLOGY
- Down-Regulation of the Met Receptor Tyrosine Kinase by Presenilin-dependent Regulated Intramembrane Proteolysis
- (2009) Bénédicte Foveau et al. MOLECULAR BIOLOGY OF THE CELL
- Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis
- (2009) Y Li et al. ONCOGENE
- Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia
- (2008) Chih-Chen Hong et al. CANCER LETTERS
- HER4 Intracellular Domain (4ICD) Activity in the Developing Mammary Gland and Breast Cancer
- (2008) Frank E. Jones JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started